{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T13:37:37Z","timestamp":1782135457058,"version":"3.54.5"},"reference-count":104,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,7,2]],"date-time":"2021-07-02T00:00:00Z","timestamp":1625184000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>In China, the majority of patients with hepatocellular carcinoma (HCC) result from long-term infection of hepatitis B. Pathologically, HCC is characterized by rich blood supply, multicentric origins, early vascular invasion and intrahepatic metastasis. Therefore, HCC is not a local disease but a systemic disease at the beginning of its occurrence. For this reason, a comprehensive treatment strategy should be adopted in the management of HCC, including local treatments (such as surgical resection, radiofrequency ablation, microwave ablation, chemical ablation and cryoablation, etc.), organ-level treatments [such as transcatheter arterial infusion of chemotherapy and transcatheter arterial chemoembolization (TACE)], and systemic treatments (such as immunotherapy, antiviral therapy and molecular targeted therapy, etc.). This consensus sets forth the minimally-invasive and multidisciplinary comprehensive guideline of HCC, focusing on the following eight aspects (1) using hepaticarteriography, CT hepatic arteriography (CTHA), CT arterial portography (CTAP), lipiodol CT (Lp-CT), TACE-CT to find the intrahepatic lesion and make precise staging (2) TACE combined with ablation or ablation as the first choice of treatment for early stage or small HCC, while other therapies are considered only when ablation is not applicable (3) infiltrating HCC should be regarded as an independent subtype of HCC (4) minimally-invasive comprehensive treatment could be adopted in treating metastatic lymph nodes (5) multi-level subdivision of M-staging should be used for individualized treatment and predicting prognosis (6) HCC with severe hepatic decompensation is the only candidate criterion for liver transplantation (7) bio-immunotherapy, traditional Chinese medicine therapy, antiviral therapy, and psychosocial and psychopharmacological interventions should be advocated through the whole course of HCC treatment (8) implementation of multicenter randomized controlled trials of minimally-invasive therapy versus surgery for early and intermediate stage HCC is recommended.<\/jats:p>","DOI":"10.3389\/fonc.2021.621834","type":"journal-article","created":{"date-parts":[[2021,7,2]],"date-time":"2021-07-02T12:55:57Z","timestamp":1625230557000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Consensus of Minimally Invasive and Multidisciplinary Comprehensive Treatment for Hepatocellular Carcinoma \u2013 2020 Guangzhou Recommendations"],"prefix":"10.3389","volume":"11","author":[{"given":"Qi-Feng","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon Chun-ho","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Hong","family":"Chou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyunchul","family":"Rhim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoming","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lujun","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annan","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhua","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fujun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijun","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangkui","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhimei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengxuan","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueyong","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Kuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianjun","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peihong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,7,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA: Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21338","article-title":"Cancer Statistics in China, 2015","volume":"66","author":"Chen","year":"2016","journal-title":"CA: Cancer J Clin"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.2188\/jea.JE20100190","article-title":"Hepatitis B and C Virus Infection and Hepatocellular Carcinoma in China: A Review of Epidemiology and Control Measures","volume":"21","author":"Tanaka","year":"2011","journal-title":"J Epidemiol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.2147\/JMDH.S41206","article-title":"Multidisciplinary Management of Hepatocellular Carcinoma: A Model for Therapy","volume":"6","author":"Cohen","year":"2013","journal-title":"J Multidiscip Healthcare"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.issn.0376-2491.2015.21.020","article-title":"Strategies of Minimally Invasive and Multidisciplinary Diagnosis and Treatment for Hepatocellular Carcinoma in China","volume":"95","author":"Dong","year":"2015","journal-title":"Zhonghua yi xue za zhi"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-004-0552-0","article-title":"Randomized Controlled Trial of Screening for Hepatocellular Carcinoma","volume":"130","author":"Zhang","year":"2004","journal-title":"J Cancer Res Clin Oncol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.30.8.704","article-title":"Serum Alpha-Fetoprotein Levels in Patients With Acute and Chronic Liver Disease. Relation to Hepatocellular Regeneration and Development of Primary Liver Cell Carcinoma","volume":"30","author":"Eleftheriou","year":"1977","journal-title":"J Clin Pathol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2008.05395.x","article-title":"Des-Gamma-Carboxyprothrombin, Alpha-Fetoprotein and AFP-L3 in Patients With Chronic Hepatitis, Cirrhosis and Hepatocellular Carcinoma","volume":"23","author":"Durazo","year":"2008","journal-title":"J Gastroenterol Hepatol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/nmat4997","article-title":"Circulating Tumour DNA Methylation Markers for Diagnosis and Prognosis of Hepatocellular Carcinoma","volume":"16","author":"Xu","year":"2017","journal-title":"Nat Mater"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1159\/000367742","article-title":"Novel Imaging Diagnosis for Hepatocellular Carcinoma: Consensus From the 5th Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE 2014)","volume":"4","author":"Chen","year":"2015","journal-title":"Liver Cancer"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-015-3873-2","article-title":"Consensus Report From the 7th International Forum for Liver Magnetic Resonance Imaging","volume":"26","author":"Merkle","year":"2016","journal-title":"Eur Radiol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/hep.21966","article-title":"Diagnosis of Hepatic Nodules 20\u00a0Mm or Smaller in Cirrhosis: Prospective Validation of the Noninvasive Diagnostic Criteria for Hepatocellular Carcinoma","volume":"47","author":"Forner","year":"2008","journal-title":"Hepatology"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-010-9165-7","article-title":"Asian Pacific Association for the Study of the Liver Consensus Recommendations on Hepatocellular Carcinoma","volume":"4","author":"Omata","year":"2010","journal-title":"Hepatol Int"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-012-2336-0","article-title":"Diffuse Infiltrative Hepatocellular Carcinoma: Assessment of Presentation, Treatment, and Outcomes","volume":"19","author":"Kneuertz","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/s11605-011-1614-7","article-title":"Infiltrating Hepatocellular Carcinoma: Seeing the Tree Through the Forest","volume":"15","author":"Demirjian","year":"2011","journal-title":"J\u00a0Gastrointestinal Surg: Off J Soc Surg Alimentary Tract"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.14131996","article-title":"Small (<\/=1-Cm) Hepatocellular Carcinoma: Diagnostic Performance and Imaging Features at Gadoxetic Acid-Enhanced MR Imaging","volume":"271","author":"Yu","year":"2014","journal-title":"Radiology"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1080\/028418500127345695","article-title":"Diagnostic Accuracy of Helical CT Arterial Portography and CT Hepatic Arteriography for Hypervascular Hepatocellular Carcinoma in Chronic Liver Damage. An ROC Analysis","volume":"41","author":"Makita","year":"2000","journal-title":"Acta Radiol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-011-9310-y","article-title":"Characteristics of Hepatocellular Carcinoma Nodules Newly Detected by Computed Tomography During Arteriography and Arterial Portography: Preliminary Report of a Randomized Controlled Trial","volume":"6","author":"Ohki","year":"2012","journal-title":"Hepatol Int"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2013.109","article-title":"CT With Hepatic Arterioportography as a Pretreatment Examination for Hepatocellular Carcinoma Patients: A Randomized Controlled Trial","volume":"108","author":"Ohki","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2522081414","article-title":"Hepatocarcinogenesis: Multistep Changes of Drainage Vessels at CT During Arterial Portography and Hepatic Arteriography\u2013Radiologic-Pathologic Correlation","volume":"252","author":"Kitao","year":"2009","journal-title":"Radiology"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1007\/s11604-010-0442-0","article-title":"Radiological Assessment of Hepatic Vein Invasion by Hepatocellular Carcinoma Using Combined Computed Tomography Hepatic Arteriography and Computed Tomography Arterial Portography","volume":"28","author":"Nishie","year":"2010","journal-title":"Jpn J Radiol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2006.08.125","article-title":"Is Post-Lipiodol CT Better Than I.V. Contrast CT Scan for Early Detection of HCC? A Single Liver Transplant Center Experience","volume":"38","author":"Rizvi","year":"2006","journal-title":"Transplant Proc"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v11.i2.200","article-title":"Detection of Hypervascular Hepatocellular Carcinoma: Comparison of Multi-Detector CT With Digital Subtraction Angiography and Lipiodol CT","volume":"11","author":"Zheng","year":"2005","journal-title":"World J Gastroenterol"},{"key":"B24","article-title":"CT Portography and Post-Lipiodol CT in the Preinterventional Work-Up of Primary and Secondary Liver Tumors. A Single Center Experience","volume":"46","author":"Malagari","year":"1999","journal-title":"Hepato-Gastroenterology"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(98)80324-3","article-title":"Diagnostic Value and Tolerance of Lipiodol-Computed Tomography for the Detection of Small Hepatocellular Carcinoma: Correlation With Pathologic Examination of Explanted Livers","volume":"28","author":"Bizollon","year":"1998","journal-title":"J Hepatol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1159\/000082094","article-title":"A Strategy for Early Detection of Recurrent Hepatocellular Carcinoma Following Initial Remission by Transcatheter Arterial Chemoembolization","volume":"48","author":"Chung","year":"2005","journal-title":"Intervirology"},{"key":"B27","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1177\/02841851960371P114","article-title":"Small Hepatocellular Carcinoma. Detection With US, CT, MR Imaging, DSA, and Lipiodol-CT","volume":"37","author":"Bartolozzi","year":"1996","journal-title":"Acta Radiol"},{"key":"B28","article-title":"[Hepatocellular Carcinoma in Cirrhosis: Semeiology and Performance of Magnetic Resonance Imaging and Lipiodol Computed Tomography]","volume":"23","author":"Marcato","year":"1999","journal-title":"Gastroenterologie Clin Biol"},{"key":"B29","volume-title":"Minimally Invasive and Multidisciplinary Diagnosis and Treatment for Hepatocellular Carcinoma","author":"Wu","year":"2003"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22282","article-title":"Biopsy Diagnosis of Hepatocellular Carcinoma","volume":"47","author":"Caturelli","year":"2008","journal-title":"Hepatology"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.9157","article-title":"Management of Hepatocellular Carcinoma: An Overview of Major Findings From Meta-Analyses","volume":"7","author":"Qi","year":"2016","journal-title":"Oncotarget"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011650.pub2","article-title":"Management of People With Early- or Very Early-Stage Hepatocellular Carcinoma: An Attempted Network Meta-Analysis","volume":"3","author":"Majumdar","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3760\/j:issn:0376-2491.2006.12.003","article-title":"[Surgical Resection Versus Percutaneous Thermal Ablation for Early-Stage Hepatocellular Carcinoma: A Randomized Clinical Trial]","volume":"86","author":"Lu","year":"2006","journal-title":"Zhonghua yi xue za zhi"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7819-11-190","article-title":"Radiofrequency Ablation Versus Hepatic Resection for the Treatment of Early-Stage Hepatocellular Carcinoma Meeting Milan Criteria: A Systematic Review and Meta-Analysis","volume":"11","author":"Duan","year":"2013","journal-title":"World J Surg Oncol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.ejso.2006.10.040","article-title":"Radiofrequency Ablation Permits an Effective Treatment for Colorectal Liver Metastasis","volume":"33","author":"Abitabile","year":"2007","journal-title":"Eur J Surg Oncol: J Eur Soc Surg Oncol Br Assoc Surg Oncol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s40880-017-0183-x","article-title":"Microwave Ablation is as Effective as Radiofrequency Ablation for Very-Early-Stage Hepatocellular Carcinoma","volume":"36","author":"Xu","year":"2017","journal-title":"Chin J Cancer"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.11110817","article-title":"Radiofrequency Ablation Versus Hepatic Resection for the Treatment of Hepatocellular Carcinomas 2\u00a0Cm or Smaller: A Retrospective Comparative Study","volume":"262","author":"Peng","year":"2012","journal-title":"Radiology"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003046.pub3","article-title":"Radiofrequency (Thermal) Ablation Versus No Intervention or Other Interventions for Hepatocellular Carcinoma","volume":"12","author":"Weis","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvir.2009.11.025","article-title":"Percutaneous Ablation of Hepatocellular Carcinoma: Current Status","volume":"21","author":"McWilliams","year":"2010","journal-title":"J Vasc Interventional Radiol: JVIR"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.11.7656","article-title":"Percutaneous Tumor Ablation for Hepatocellular Carcinoma","volume":"197","author":"Gervais","year":"2011","journal-title":"AJR Am J Roentgenology"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1177\/000313481107701140","article-title":"Role of High-Intensity Focused Ultrasound in Treatment of Hepatocellular Carcinoma","volume":"77","author":"Shen","year":"2011","journal-title":"Am Surgeon"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0b013e3182822c02","article-title":"Survival Analysis of High-Intensity Focused Ultrasound Therapy Versus Radiofrequency Ablation in the Treatment of Recurrent Hepatocellular Carcinoma","volume":"257","author":"Chan","year":"2013","journal-title":"Ann Surg"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.issn.0376-2491.2009.11.009","article-title":"[Clinical Effect of Transcatheter Arterial Chemoembolization Combined With High Intensity Focused Ultrasound Ablation in Treatment of Large Hepatocellular Carcinoma]","volume":"89","author":"Li","year":"2009","journal-title":"Zhonghua yi xue za zhi"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1002\/jso.23280","article-title":"Safety and Early Efficacy of Irreversible Electroporation for Hepatic Tumors in Proximity to Vital Structures","volume":"107","author":"Cannon","year":"2013","journal-title":"J Surg Oncol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamcollsurg.2012.04.029","article-title":"Ablation of Perivascular Hepatic Malignant Tumors With Irreversible Electroporation","volume":"215","author":"Kingham","year":"2012","journal-title":"J Am Coll Surgeons"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1097\/RLI.0b013e318274b0df","article-title":"Irreversible Electroporation in Porcine Liver: Short- and Long-Term Effect on the Hepatic Veins and Adjacent Tissue by CT With Pathological Correlation","volume":"47","author":"Lee","year":"2012","journal-title":"Invest Radiol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28453","article-title":"Lipiodol Transarterial Chemoembolization for Hepatocellular Carcinoma: A Systematic Review of Efficacy and Safety Data","volume":"64","author":"Lencioni","year":"2016","journal-title":"Hepatology"},{"key":"B48","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1093\/jnci\/djs464","article-title":"Roles Played by Chemolipiodolization and Embolization in Chemoembolization for Hepatocellular Carcinoma: Single-Blind, Randomized Trial","volume":"105","author":"Shi","year":"2013","journal-title":"J Natl Cancer Inst"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-016-4488-y","article-title":"Liver and Biliary Damages Following Transarterial Chemoembolization of Hepatocellular Carcinoma: Comparison Between Drug-Eluting Beads and Lipiodol Emulsion","volume":"27","author":"Monier","year":"2017","journal-title":"Eur Radiol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s00270-009-9711-7","article-title":"Prospective Randomized Study of Doxorubicin-Eluting-Bead Embolization in the Treatment of Hepatocellular Carcinoma: Results of the PRECISION V Study","volume":"33","author":"Lammer","year":"2010","journal-title":"Cardiovasc Interventional Radiol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.5754\/hge10240","article-title":"Safety and Efficacy of Trans Arterial Chemoembolization With Drug-Eluting Beads in Hepatocellular Cancer: A Systematic Review","volume":"59","author":"Martin","year":"2012","journal-title":"Hepato-gastroenterology"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.5754\/hge121025","article-title":"Doxorubicin-Eluting Bead Versus Conventional TACE for Unresectable Hepatocellular Carcinoma: A Meta-Analysis","volume":"60","author":"Gao","year":"2013","journal-title":"Hepato-Gastroenterology"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1080\/00365521.2019.1632925","article-title":"Comparison of Lipiodol Infusion and Drug-Eluting Beads Transarterial Chemoembolization of Hepatocellular Carcinoma in a Real-Life Setting","volume":"54","author":"Karalli","year":"2019","journal-title":"Scand J Gastroenterol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1002\/lt.21999","article-title":"Report of a National Conference on Liver Allocation in Patients With Hepatocellular Carcinoma in the United States","volume":"16","author":"Pomfret","year":"2010","journal-title":"Liver Transplant: Off Publ Am Assoc Study Liver Dis Int Liver Transplant Soc"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2019181991","article-title":"Radiofrequency Ablation Following Downstaging of Hepatocellular Carcinoma by Using Transarterial Chemoembolization: Long-Term Outcomes","volume":"293","author":"Shi","year":"2019","journal-title":"Radiology"},{"key":"B56","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s00432-013-1528-8","article-title":"Treatment Outcomes of Transcatheter Arterial Chemoembolization Combined With Local Ablative Therapy Versus Monotherapy in Hepatocellular Carcinoma: A Meta-Analysis","volume":"140","author":"Gu","year":"2014","journal-title":"J Cancer Res Clin Oncol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.issn.0376-2491.2010.41.009","article-title":"[Comparative Analysis of TACE Alone or Plus RFA in the Treatment of 167 Cases of Intermediate and Advanced Staged Primary Hepatocellular Carcinoma]","volume":"90","author":"Zhao","year":"2010","journal-title":"Zhonghua yi xue za zhi"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1007\/s00270-017-1736-8","article-title":"Transarterial Chemoembolization Monotherapy Versus Combined Transarterial Chemoembolization-Microwave Ablation Therapy for Hepatocellular Carcinoma Tumors <\/=5 Cm: A Propensity Analysis at a Single Center","volume":"40","author":"Chen","year":"2017","journal-title":"Cardiovasc Interventional Radiol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1159\/000348325","article-title":"Treatment for Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis: The Emerging Role for Radioembolization Using Yttrium-90","volume":"84","author":"Lau","year":"2013","journal-title":"Oncology"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1111\/liv.12083","article-title":"Consensus Recommendations and Review by an International Expert Panel on Interventions in Hepatocellular Carcinoma (EPOIHCC)","volume":"33","author":"Park","year":"2013","journal-title":"Liver Int: Off J Int Assoc Study Liver"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1159\/000488035","article-title":"Guidelines for Diagnosis and Treatment of Primary Liver Cancer in China (2017 Edition)","volume":"7","author":"Zhou","year":"2018","journal-title":"Liver Cancer"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)00198-9","article-title":"Adjuvant Sorafenib for Hepatocellular Carcinoma After Resection or Ablation (STORM): A Phase 3, Randomised, Double-Blind, Placebo-Controlled Trial","volume":"16","author":"Bruix","year":"2015","journal-title":"Lancet Oncol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1007\/s11547-014-0413-0","article-title":"Combination of Intra-Arterial Therapies and Sorafenib: Is There a Clinical Benefit","volume":"119","author":"Chapiro","year":"2014","journal-title":"La Radiologia Med"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-013-2872-x","article-title":"Combination Trans Arterial Chemoembolization (TACE) Plus Sorafenib for the Management of Unresectable Hepatocellular Carcinoma: A Systematic Review of the Literature","volume":"58","author":"Abdel-Rahman","year":"2013","journal-title":"Digestive Dis Sci"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-014-1684-5","article-title":"Sorafenib Enhances Effects of Transarterial Chemoembolization for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis","volume":"140","author":"Fu","year":"2014","journal-title":"J Cancer Res Clin Oncol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2016.01.012","article-title":"Sorafenib or Placebo Plus TACE With Doxorubicin-Eluting Beads for Intermediate Stage HCC: The SPACE Trial","volume":"64","author":"Lencioni","year":"2016","journal-title":"J Hepatol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"516","DOI":"10.3390\/cancers10120516","article-title":"Combination Therapy After TACE for Hepatocellular Carcinoma With Macroscopic Vascular Invasion: Stereotactic Body Radiotherapy Versus Sorafenib","volume":"10","author":"Shen","year":"2018","journal-title":"Cancers"},{"key":"B68","article-title":"The Efficacy of Combined Transarterial Chemoembolization and 3-Dimensional Conformal Radiotherapy for Hepatocellular Carcinoma With Main Portal Vein Thrombosis","volume":"57","author":"Park","year":"2010","journal-title":"Hepato-Gastroenterology"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2012.1626","article-title":"Phase I\/II Study of Immunotherapy Using Tumor Antigen-Pulsed Dendritic Cells in Patients With Hepatocellular Carcinoma","volume":"41","author":"Tada","year":"2012","journal-title":"Int J Oncol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1097\/CJI.0b013e3182948452","article-title":"Cytokine-Induced Killer Cells in Combination With Transcatheter Arterial Chemoembolization and Radiofrequency Ablation for Hepatocellular Carcinoma Patients","volume":"36","author":"Huang","year":"2013","journal-title":"J Immunother"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.3760\/j:issn:0376-2491.2006.26.006","article-title":"[Cytokine-Induced Killer Cell Fusion to Lower Recurrence of Hepatocellular Carcinoma After Transcatheter Arterial Chemoembolization Sequentially Combined With Radiofrequency Ablation: A Randomized Trial]","volume":"86","author":"Zhao","year":"2006","journal-title":"Zhonghua yi xue za zhi"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02654-4","article-title":"Adoptive Immunotherapy to Lower Postsurgical Recurrence Rates of Hepatocellular Carcinoma: A Randomised Trial","volume":"356","author":"Takayama","year":"2000","journal-title":"Lancet"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2018-315983","article-title":"Effect of Huaier Granule on Recurrence After Curative Resection of HCC: A Multicentre, Randomised Clinical Trial","volume":"67","author":"Chen","year":"2018","journal-title":"Gut"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.issn.1007-3418.2014.05.001","article-title":"[Expert Consensus on Antiviral Therapy to Treat Hepatitis B\/C Virus-Related Hepatocellular Carcinoma]","volume":"22","author":"Ye","year":"2014","journal-title":"Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chin J Hepatol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2019.0019","article-title":"Guidelines Insights: Hepatobiliary Cancers, Version 2.2019","volume":"17","author":"Benson","year":"2019","journal-title":"J Natl Compr Cancer Network: JNCCN"},{"key":"B76","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","article-title":"EASL Clinical Practice Guidelines: Management of Hepatocellular Carcinoma","volume":"69","year":"2018","journal-title":"J Hepatol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1111\/hepr.13411","article-title":"Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2017 (4th JSH-HCC Guidelines) 2019 Update","volume":"49","author":"Kokudo","year":"2019","journal-title":"Hepatol Res: Off J Jpn Soc Hepatol"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.issn.1007-3418.2020.02.004","article-title":"[Guidelines for Diagnosis and Treatment of Primary Liver Cancer in China (2019 Edition)]","volume":"28","year":"2020","journal-title":"Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chin J Hepatol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000001178","article-title":"Surgical Resection Versus Radiofrequency Ablation for Single Hepatocellular Carcinoma <\/= 2\u00a0Cm in a Propensity Score Model","volume":"263","author":"Liu","year":"2016","journal-title":"Ann Surg"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1097\/01.sla.0000201480.65519.b8","article-title":"A Prospective Randomized Trial Comparing Percutaneous Local Ablative Therapy and Partial Hepatectomy for Small Hepatocellular Carcinoma","volume":"243","author":"Chen","year":"2006","journal-title":"Ann Surg"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.9539","article-title":"Quality of Life After Surgical Resection Compared With Radiofrequency Ablation for Small Hepatocellular Carcinomas","volume":"101","author":"Huang","year":"2014","journal-title":"Br J Surg"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.15141483","article-title":"Small Hepatocellular Carcinoma: Radiofrequency Ablation Versus Nonanatomic Resection\u2013Propensity Score Analyses of Long-Term Outcomes","volume":"275","author":"Kang","year":"2015","journal-title":"Radiology"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.30531","article-title":"Comparative Effectiveness of First-Line Radiofrequency Ablation Versus Surgical Resection and Transplantation for Patients With Early Hepatocellular Carcinoma","volume":"123","author":"Kutlu","year":"2017","journal-title":"Cancer"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2013.04.009","article-title":"Cost-Effectiveness of Hepatic Resection Versus Percutaneous Radiofrequency Ablation for Early Hepatocellular Carcinoma","volume":"59","author":"Cucchetti","year":"2013","journal-title":"J Hepatol"},{"key":"B85","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3348\/kjr.2016.17.1.93","article-title":"Efficacy and Safety of Radiofrequency Ablation Combined With Transcatheter Arterial Chemoembolization for Hepatocellular Carcinomas Compared With Radiofrequency Ablation Alone: A Time-To-Event Meta-Analysis","volume":"17","author":"Wang","year":"2016","journal-title":"Korean J Radiol"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.42.9936","article-title":"Radiofrequency Ablation With or Without Transcatheter Arterial Chemoembolization in the Treatment of Hepatocellular Carcinoma: A Prospective Randomized Trial","volume":"31","author":"Peng","year":"2013","journal-title":"J Clin Oncol: Off J Am Soc Clin Oncol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2014.12.007","article-title":"Radiofrequency Ablation Plus Drug-Eluting Beads Transcatheter Arterial Chemoembolization for the Treatment of Single Large Hepatocellular Carcinoma","volume":"47","author":"Iezzi","year":"2015","journal-title":"Digestive Liver Dis: Off J Ital Soc Gastroenterol Ital Assoc Study Liver"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1136\/gut.48.1.110","article-title":"Evidence for an Association Between the Aetiology of Cirrhosis and Pattern of Hepatocellular Carcinoma Development","volume":"48","author":"Benvegnu","year":"2001","journal-title":"Gut"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2017-314138","article-title":"FOXAI: A Phase II Trial Evaluating the Efficacy and Safety of Hepatic Arterial Infusion of Oxaliplatin Plus Fluorouracil\/Leucovorin for Advanced Hepatocellular Carcinoma","volume":"67","author":"Lyu","year":"2018","journal-title":"Gut"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2018.02.008","article-title":"Hepatic Arterial Infusion of Oxaliplatin Plus Fluorouracil\/Leucovorin vs. Sorafenib for Advanced Hepatocellular Carcinoma","volume":"69","author":"Lyu","year":"2018","journal-title":"J Hepatol"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.44.5643","article-title":"Randomized, Multicenter, Open-Label Study of Oxaliplatin Plus Fluorouracil\/Leucovorin Versus Doxorubicin as Palliative Chemotherapy in Patients With Advanced Hepatocellular Carcinoma From Asia","volume":"31","author":"Qin","year":"2013","journal-title":"J Clin Oncol: Off J Am Soc Clin Oncol"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2016151807","article-title":"Percutaneous CT-Guided Radiofrequency Ablation for Lymph Node Oligometastases From Hepatocellular Carcinoma: A Propensity Score-Matching Analysis","volume":"282","author":"Pan","year":"2017","journal-title":"Radiology"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1159\/000327572","article-title":"Management of Patients With Hepatocellular Carcinoma and Extrahepatic Metastasis","volume":"29","author":"Lee","year":"2011","journal-title":"Digestive Dis"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.issn.0376-2491.2012.41.005","article-title":"[Clinical Value of CT-Guided Radiofrequency Ablation for Retroperitoneal Metastatic Lymph Node From PHC]","volume":"92","author":"Gao","year":"2012","journal-title":"Zhonghua yi xue za zhi"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1016\/j.acra.2012.04.003","article-title":"Radiofrequency Ablation of Retroperitoneal Metastatic Lymph Nodes From Hepatocellular Carcinoma","volume":"19","author":"Gao","year":"2012","journal-title":"Acad Radiol"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2017162756","article-title":"Radiofrequency Ablation Versus Hepatic Resection for Small Hepatocellular Carcinoma: Systematic Review of Randomized Controlled Trials With Meta-Analysis and Trial Sequential Analysis","volume":"287","author":"Xu","year":"2018","journal-title":"Radiology"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2016151344","article-title":"Image-Based Multilevel Subdivision of M1 Category in TNM Staging System for Metastatic Nasopharyngeal Carcinoma","volume":"280","author":"Shen","year":"2016","journal-title":"Radiology"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2016.25","article-title":"The Future of Cancer Treatment: Immunomodulation, CARs and Combination Immunotherapy","volume":"13","author":"Khalil","year":"2016","journal-title":"Nat Rev Clin Oncol"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)31046-2","article-title":"Nivolumab in Patients With Advanced Hepatocellular Carcinoma (CheckMate 040): An Open-Label, non-Comparative, Phase 1\/2 Dose Escalation and Expansion Trial","volume":"389","author":"El-Khoueiry","year":"2017","journal-title":"Lancet"},{"key":"B100","first-page":"693606","article-title":"FDA Approves Nivolumab Plus Ipilimumab for the Treatment of Advanced HCC","volume":"34","author":"Wright","year":"2020","journal-title":"Oncol (Williston Park)"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2006.09.004","article-title":"Immunotherapy of Hepatocellular Carcinoma","volume":"45","author":"Greten","year":"2006","journal-title":"J Hepatol"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.4268\/cjcmm20141243","article-title":"[Prospective Randomized Controlled Study on Advanced Primary Hepatic Cancer Treated by Ganfule Prescription]","volume":"39","author":"Gao","year":"2014","journal-title":"Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China J Chin Mater Med"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.48.5896","article-title":"Effect of Antiviral Treatment With Nucleotide\/Nucleoside Analogs on Postoperative Prognosis of Hepatitis B Virus-Related Hepatocellular Carcinoma: A Two-Stage Longitudinal Clinical Study","volume":"31","author":"Yin","year":"2013","journal-title":"J Clin Oncol: Off J Am Soc Clin Oncol"},{"key":"B104","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1097\/SLA.0000000000000858","article-title":"Antiviral Therapy Improves Postoperative Survival in Patients With Hepatocellular Carcinoma: A Randomized Controlled Trial","volume":"261","author":"Huang","year":"2015","journal-title":"Ann Surg"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2021.621834\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,2]],"date-time":"2021-07-02T12:56:11Z","timestamp":1625230571000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2021.621834\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,2]]},"references-count":104,"alternative-id":["10.3389\/fonc.2021.621834"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2021.621834","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,2]]},"article-number":"621834"}}